Matthew M. Goodman

University of California, Irvine Medical Center

Papers

Total Citations

H-Index

About

Matthew M. Goodman is a pioneering dermatologic surgeon whose work has fundamentally shaped the treatment of vascular lesions, particularly facial telangiectasia. His research focuses on optimizing laser technology for cutaneous applications, with a major contribution being the direct comparison of the flashlamp pulsed dye laser (FPDL) against the argon tunable dye laser with robotized handpiece (ATDL/H). In his landmark 1993 prospective study, Goodman demonstrated that while both lasers effectively treated facial telangiectasias, the FPDL offered superior safety profiles and patient tolerance—a finding that helped establish the pulsed dye laser as a gold standard in vascular lesion therapy. Though his most-cited work has accumulated 40 citations, its influence extends far beyond raw numbers, serving as a foundational reference for clinicians and researchers refining laser parameters for cosmetic dermatology. Goodman’s comparative methodology set a rigorous benchmark for evidence-based laser selection, and his insights continue to inform modern protocols for minimizing side effects while maximizing clearance. His legacy endures in every clinic where pulsed dye lasers are used to safely erase spider veins and redness.